Fmoc-Asp(OMpe)-OH |
| Catalog No.GA21537 |
The OMpe (O-3-methylpent-3-yl) side chain protecting group significantly reduces aspartimide formation, an undesired side-chain reaction encountered with the repetitive piperidine treatment needed for Fmoc removal.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 180675-08-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The OMpe (O-3-methylpent-3-yl) side chain protecting group significantly reduces aspartimide formation, an undesired side-chain reaction encountered with the repetitive piperidine treatment needed for Fmoc removal.
Average Rating: 5 (Based on Reviews and 15 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *